A composite probiotic containing Lactobacillus rhamnosus Glory LG12 and its application in regulating intestinal flora
By using probiotics such as Lactobacillus rhamnosus, combined with Pueraria root, apricotum extract and complex carrier, the problem of low survival rate of probiotics in acidic environments is solved, and more effective regulation of intestinal bacteria and health improvement is achieved. .
Patent Information
- Application Number
- CN202410403338.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-03
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-04-03
AI Technical Summary
The survival rate of existing probiotics under strong acid conditions is low, making it difficult to survive and play a role in the human gastric acid environment, resulting in limited in the regulation of intestinal microbiota.
The combination of four probiotics, including Lactobacillus rhamnosus Glory LG12, combines the extract of Pueraria root and apricotum and a composite carrier to enhance the acid resistance and bile salts of the probiotics, and extract it through enzymatic decomposition, fermentation and alcohol precipitation. Active ingredients, forming stable complex carriers to improve intestinal colonization and proliferation.
It significantly improves the survival rate and reproductive ability of probiotics in the intestine, enhances the regulation effect of intestinal flora, improves intestinal health and immune function, and effectively repairs the bacterial disorder caused by antibiotics.
Smart Images

Figure CN118160930B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of microbial agents, and specifically relates to a composite probiotic composition containing Lactobacillus rhamnosus GloryLG12 and an application thereof in regulating intestinal flora. Background Art
[0002] The intestine is the largest immune organ in the human body. The total number of microorganisms in the intestine of an adult is 10 12 -10 14 , 10 times higher than the number of human cells. The composition of intestinal microorganisms is easily changed by environmental influences, such as the use of antibiotics, changes in dietary patterns, etc. Intestinal flora imbalance increases the risk of disease and causes a variety of health problems related to the gastrointestinal tract and distal sites (such as the brain, lungs, liver, and vagina). Intestinal microorganisms affect our lives not only by metabolizing food and eliminating pathogens, but also by regulating mucosal immune responses. The intestinal flora can be regulated by probiotics, and when present in sufficient amounts, they bring health benefits to the host's intestinal microbiota.
[0003] In the human microbiome, the intestinal flora is a very small but critical part, involved in regulating the host's homeostasis, pathophysiology and physiological processes. In recent years, more and more researchers have focused their attention on the intestinal flora and analyzed the flora in different health states. The results show that the intestinal flora plays a vital role in intestinal health and various diseases. How to have a healthy and stable intestinal flora is also our research goal, among which Lactobacillus paracasei is an important part.
[0004] Probiotics are "live microorganisms that, when administered in adequate numbers, can confer a health benefit on the host". Probiotics can protect the host from pathogens, fungi and their carcinogenic products, nitrosamines, by adhering to and colonizing the epithelium and inhibiting the adhesion and colonization of pathogens. Some lactobacilli can inhibit pathogens by producing and releasing potent antimicrobial peptides (AMPs) and low molecular weight compounds such as bacteriocins and microproteins. Therefore, probiotics can inhibit the growth of pathogens, regulate intestinal flora and maintain the intestinal barrier by competing with pathogenic bacteria. Compared with drug therapy, probiotic therapy can alleviate antibiotic-induced dysbiosis and the proliferation of drug-resistant strains, and has great research and application potential. Studies have evaluated the therapeutic effects of probiotics in the treatment of infectious diarrhea and antibiotic-associated diarrhea through randomized controlled trials and meta-molecules, indicating that probiotics are safe and effective for the treatment of diarrhea caused by antibiotics. In addition, it has been found that apple juice fermented by Lactobacillus plantarum CICC21809 can treat diarrhea caused by antibiotics and improve the damaged intestinal flora. Lactobacillus paracasei is a more beneficial and useful probiotic in preventing and treating intestinal flora disorders.
[0005] Chinese patent application No. 202010899891.4 discloses a Bifidobacterium lactis MN-Gup for improving obesity and its characteristic intestinal flora. The Bifidobacterium lactis MN-Gup has the functions of regulating the characteristic intestinal flora of obesity, targeted improvement and regulation of the characteristic intestinal flora of obesity, increasing the abundance of beneficial bacteria related to obesity, reducing the abundance of harmful bacteria related to obesity, improving and restoring the health of intestinal flora; inhibiting inflammatory factors IL-1β, TNF-α, IL-6 and INF-γ, and improving obesity-related inflammatory responses; reducing triglycerides, cholesterol and / or low-density lipoprotein, and increasing high-density lipoprotein, so as to lower blood lipids and inhibit fat accumulation; inhibiting adipose tissue degeneration; and comprehensively preventing, alleviating or improving obesity or weight gain through the above mechanisms. However, the patent did not test the acid and alkali resistance of Bifidobacterium lactis MN-Gup. Generally, the survival rate of probiotics is low under strong acidic conditions, while the human gastric acid environment is usually at pH = 2. After probiotics are digested in the stomach, their survival rate is very low, which greatly reduces the effect of improving intestinal flora by supplementing probiotics. The effect of regulating intestinal flora can be further improved. Summary of the invention
[0006] In view of the shortcomings of the prior art, the object of the present invention is to provide a composite probiotic composition containing Lactobacillus rhamnosus GloryLG12 and its application in regulating intestinal flora. The four probiotics used have good acid and bile salt resistance, strong survival and colonization ability in the stomach and intestines, and synergistically improve the function of significantly improving intestinal flora disorders caused by ampicillin.
[0007] To achieve the above object, the present invention provides the following technical solutions:
[0008] A composite probiotic composition containing Lactobacillus rhamnosus Glory LG12, the composite probiotic composition consisting of a probiotic mixture and a functional mixture, the probiotic mixture being formed by mixing Lactobacillus paracasei Glory LP16, Lactobacillus rhamnosus Glory LG12, Bifidobacterium animalis subspecies lactis XLTG11, and Lactobacillus acidophilus LA-06, and the functional mixture being formed by a kudzu root extract, a roxburghii extract, and a composite carrier.
[0009] Pueraria root is a natural plant that can be used as both medicine and food. It is known as "Southern Pueraria and Northern Ginseng" in China. Pueraria root resources are abundant. It contains more than 60% dietary fiber. It not only contains rich isoflavones, lignocellulosic substances, etc., which not only have good health functions for the human body, but also contains rich crude protein and crude fiber components. Pueraria root polysaccharides have strong in vitro antioxidant, anti-glycosylation and immunomodulatory activities. It participates in the treatment of diseases such as glucose metabolism disorders and gastrointestinal dysfunction through its metabolites (such as short-chain fatty acids) or increasing the proportion of beneficial bacteria. It has important pharmacological functions and medicinal values.
[0010] Rosa roxburghii, also known as Wenxian fruit and Sending Spring Back, is a deciduous shrub of the genus Rosa in the Rosaceae family. Its fruit is rich in nutrients such as flavonoids, polysaccharides, vitamins, superoxide dismutase and organic acids, and has high nutritional value. In recent years, with the in-depth research of many experts on rosa roxburghii, the medicinal and edible value of rosa roxburghii has gradually been confirmed by relevant research institutes. It is currently found that rosa roxburghii has the functions of enhancing immunity, resisting radiation, anti-cancer, lowering blood lipids, lowering blood sugar, aiding digestion and anti-oxidation. Many foods and medicines related to rosa roxburghii have also appeared in people's lives. Rosa roxburghii fruit is also rich in polysaccharides, polyphenols, triterpenes, flavonoids and other active substances. Rosa roxburghii fruit polysaccharides have multiple effects such as antibacterial, anti-tumor, antioxidant, immunomodulatory, and hypoglycemic.
[0011] Preferably, the mass ratio of Lactobacillus paracasei Glory LP16, Lactobacillus rhamnosus Glory LG12, Bifidobacterium animalis subspecies lactis XLTG11, and Lactobacillus acidophilus LA-06 is 8-12:5-10:4-7:3-8.
[0012] Preferably, the mass ratio of the kudzu root extract, the roxburghii extract and the composite carrier is 35-45:20-30:15-25.
[0013] Preferably, the mass ratio of the probiotic mixture to the functional mixture is 20-35:70-100.
[0014] Preferably, the preparation method of the Pueraria root extract is as follows:
[0015] The method comprises the following steps: adding kudzu root powder to deionized water, then adding cellulase and amylase, adjusting the pH to 5-6, performing enzymolysis, inactivating the enzyme by microwave after the enzymolysis is completed, filtering, and drying the filter residue for later use; concentrating the filtrate under reduced pressure to 1 / 3 of the volume, the pressure of the reduced pressure concentration being 40-50 kpa and the temperature being 75-80°C, adding 4 times the volume of anhydrous ethanol for alcohol precipitation, then centrifuging, collecting the precipitate, and drying to obtain a filtrate extract; adding the filter residue to deionized water, then inoculating yeast to perform fermentation, collecting the supernatant by centrifugation after the fermentation is completed, sterilizing at 105°C for 20 minutes, removing the deionized water by reduced pressure distillation of the supernatant, the pressure of the reduced pressure distillation being 40-50 kpa and the temperature being 75-80°C, and obtaining a filter residue extract; and uniformly mixing the filtrate extract with the filter residue extract to obtain the product.
[0016] Preferably, the solid-liquid ratio of the kudzu root powder and deionized water is 1:15-25; the added amount of the cellulase is 3-6% of the mass of the kudzu root powder, and the added amount of the amylase is 2-4% of the mass of the kudzu root powder; the temperature of the enzymolysis is 35-40°C, and the time is 1-2h.
[0017] Preferably, the solid-liquid ratio of the filter residue and deionized water is 1:8-12, the added amount of the yeast is 1.5-2% of the filter residue mass; the fermentation temperature is 30-35°C, and the time is 18-24h; the mass ratio of the filtrate extract to the filter residue extract is 5:2-4.
[0018] Preferably, the preparation method of the roxburghii extract is as follows:
[0019] The dried roxburgh fruit is crushed and added to petroleum ether, and refluxed for deesterification for 3 times, each time for 3 hours, filtered, and the roxburgh residue is dried to obtain pretreated roxburgh powder; the pretreated roxburgh powder is added to deionized water, and then citric acid is added to perform water extraction. After the water extraction is completed, the supernatant is taken and concentrated under reduced pressure to 1 / 3 of the volume. The pressure of the reduced pressure concentration is 40-50kpa and the temperature is 75-80°C. 4 times the volume of anhydrous ethanol is added for alcohol precipitation, centrifuged, and the precipitate is washed and freeze-dried to obtain the roxburgh extract.
[0020] Preferably, the mass ratio of the pretreated roxburghii powder, deionized water and citric acid is 10:200-300:0.5-1, the water extraction temperature is 80-90°C, and the extraction time is 2-4h.
[0021] Preferably, the preparation method of the composite carrier is as follows:
[0022] 5-8g zinc oxide and 15-22g diatomaceous earth are added to 500mL deionized water, and then 3-6g citric acid is added, and the mixture is stirred and reacted at 70-80°C for 2-3h. After the reaction is completed, the mixture is filtered, washed, and dried to obtain a diatomaceous earth / zinc oxide complex. 5-10g lecithin and 2-4g cholesterol are added to 100-150g anhydrous ethanol, and the mixture is ultrasonically treated at a power of 200-300W for 20-30min to obtain a mixed solution. 20-30g diatomaceous earth / zinc oxide complex is added to 100-150g of the mixed solution, and the mixture is reacted at a constant temperature of 50-60°C for 3-4h. After the reaction is completed, the mixture is centrifuged, filtered, washed, and dried to obtain a composite carrier.
[0023] The present invention also protects the use of the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 as described above in the preparation of a product for regulating intestinal flora.
[0024] Compared with the prior art, the present invention has the following beneficial effects:
[0025] (1) The composite probiotic composition containing rhamnosus Lactobacillus Glory LG12 provided by the present invention is a composite probiotic composition comprising four probiotics, namely, Lactobacillus paracasei Glory LP16, Lactobacillus rhamnosus Glory LG12, Bifidobacterium animalis subspecies lactis XLTG11, and Lactobacillus acidophilus LA-06. Compared with a single probiotic, the composite probiotic composition has a better effect of regulating intestinal flora, and the used Lactobacillus paracasei Glory LP16 has good acid and bile salt tolerance and adhesion ability, and the rhamnosus Lactobacillus Glory LG12 has good acid and bile salt tolerance and adhesion ability. LG12 has strong survival and reproduction capabilities under the low pH conditions of gastric acid and bile, is easy to colonize, and exerts its effects in the intestines, and has high immune activity. Animal Bifidobacterium lactis subspecies XLTG11 has strong acid and bile salt resistance, high cell adhesion properties and anti-inflammatory ability in vitro. Lactobacillus acidophilus LA-06 is a symbiotic bacterium in the intestines of humans and animals. It has strong intestinal colonization ability, can secrete anti-biotin substances, and has an antagonistic effect on intestinal pathogens. These four probiotics have better tolerance to the intestine and can better exert the efficacy of probiotics.
[0026] (2) The composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 provided by the present invention is provided with a functional mixture, and the kudzu root is subjected to enzymatic hydrolysis and water extraction to extract the polysaccharides in the kudzu root, and then the kudzu root residue is fermented. During the fermentation process, the kudzu root cell wall can be destroyed to release the active ingredients inside, and the fermentation can also convert part of the insoluble dietary fiber in the kudzu root into soluble dietary fiber, thereby increasing the content of dietary fiber in the residue extract and further improving the intestinal regulation effect of the composite probiotics; the roxburghii is de-esterified and then water-extracted to increase the polysaccharide content in the roxburghii extract; the composite carrier is added, and zinc oxide and diatomaceous earth are first added to deionized water to form a suspension, and citric acid is added to activate the zinc oxide to improve the bioavailability and stability of the zinc oxide, and the mixture is stirred. The reaction forms a diatomaceous earth / zinc oxide complex, which can protect zinc oxide from decomposition in the stomach, thereby increasing the proportion of zinc oxide reaching the gastrointestinal tract and enhancing the efficacy of zinc oxide in the intestine. Then, through a constant temperature reaction, the diatomaceous earth / zinc oxide complex can be effectively combined with liposomes (lecithin and cholesterol) to form a stable coating complex, which can improve the bioavailability and stability of activated zinc oxide and the prebiotic effect of the composite carrier. The diatomaceous earth in the composite carrier can also provide a colonization site for probiotics in the intestine, promote the proliferation of probiotics, and effectively prevent harmful substances such as bacteria and toxins. Finally, the kudzu root extract, the sea buckthorn extract and the composite carrier are compounded to jointly improve the regulatory effect of the composite probiotics on the intestinal flora.
[0027] (3) The composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 provided by the present invention, through the synergistic effect between the probiotic mixture and the functional mixture, the polysaccharides and dietary fiber in the kudzu root extract can improve the proliferation and colonization of probiotics in the intestine, regulate the flora in the intestine, and then regulate human immunity. The kudzu root polysaccharide and the roxburghii polysaccharide can work together to enhance the intestinal barrier and other effects, thereby regulating the microecological balance of the intestinal flora.
[0028] Instruction Manual
[0029] Figure 1 The effect of the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 on the intestinal flora of mice is shown in the figure. Figure 1 A is Bifidobacterium, Figure 1 B is Lactobacillus, Figure 1 C is enterococcus, and D is enterobacter. Figure 1 E is Clostridium perfringens;
[0030] Figure 2 The effect of the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 on the intestinal permeability of mice is shown in the figure. Figure 2 A is the LPS content, Figure 2 B is the D-lactic acid content. DETAILED DESCRIPTION
[0031] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0032] The strain provided by the present invention, Lactobacillus paracasei Glory LP16, is classified and named: Lactobacillus paracasei, and is deposited in the General Microbiology Center (CGMCC) of the China Microbiological Culture Collection Administration, address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, with a deposit date of September 9, 2022 and a deposit number of CGMCC No. 25669.
[0033] The strain provided by the present invention, Lactobacillus rhamnosus Glory LG12, is classified and named: Lactobacillus rhamnosus, and is deposited in the General Microbiology Center (CGMCC) of the China Microbiological Culture Collection Administration, address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, with a deposit date of September 9, 2022 and a deposit number of CGMCC No. 25668.
[0034] The strain used in the present invention, Bifidobacterium animalis subsp. lactis XLTG11, is classified and named as: Bifidobacterium animalis subsp. lactis, and is deposited in the General Microbiology Center (CGMCC) of the China Microbiological Culture Collection Administration, address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, with a deposit date of October 25, 2019 and a deposit number of CGMCC No. 18738.
[0035] The strain used in the present invention, Lactobacillus acidophilus LA-06 freeze-dried powder, was purchased from Jinhua Yinhe Biotechnology Co., Ltd., with a viable count of ≥10 10 cfu / g; the zinc oxide was purchased from Xi'an Jinxiang Pharmaceutical Excipients Co., Ltd.; the diatomaceous earth was purchased from Jinan Haoke Biotechnology Co., Ltd.
[0036] The culture media involved are as follows: seed culture medium: glucose 10g / L, sucrose 50g / L, yeast extract 13g / L, sodium acetate 6g / L, diammonium citrate 5g / L, magnesium sulfate heptahydrate 0.5g / L, manganese sulfate monohydrate 0.5g / L, pH=6.2; fermentation medium: glucose 15g / L, sucrose 75g / L, yeast extract 45g / L, sodium acetate 6g / L, diammonium citrate 4g / L, magnesium sulfate heptahydrate 0.6g / L, manganese sulfate monohydrate 0.3g / L, pH=6.2.
[0037] Preparation of freeze-dried powder of Lactobacillus paracasei Glory LP16:
[0038] (1) Liquid submerged fermentation culture: Glory LP16, a preserved strain of Lactobacillus paracasei, was inoculated into 300 mL of seed culture medium at a 2% inoculum amount and incubated at 37°C and 5% CO 2 After 24 h, the inoculum was inoculated into 800 mL of seed culture medium at a rate of 3% and incubated at 37°C with 5% CO. 2 After 10 hours of culturing, the inoculum was inoculated into 200 mL of fermentation medium at a rate of 4%. The fermentation conditions were 35-37°C and anaerobic culture for 8-12 hours. When the cell density in the fermentation liquid reached 10 10cfu / mL, and the fermentation broth was collected;
[0039] (2) Preparation of freeze-dried bacterial agent: When the temperature of the fermentation liquid of Lactobacillus paracasei Glory LP16 drops to about 20°C, centrifuge to collect bacterial sludge, cool the centrifugal bacterial pipeline, collect bacterial sludge after centrifugation, then add 250g skim milk powder, 100g sucrose, and 80g trehalose as freeze-drying protective agents, dissolve and mix with 1L distillation, then spread the mixture evenly on a tray, place the tray on a partition, place a temperature probe in the material, and then freeze-dry, collect bacterial powder, and store it in a -20°C refrigerator to obtain freeze-dried bacterial powder of Lactobacillus paracasei Glory LP16, the number of viable bacteria of which is 10 10 cfu / g.
[0040] Preparation of freeze-dried powder of Lactobacillus rhamnosus Glory LG12:
[0041] (1) Liquid submerged fermentation culture: Glory LG12 preserved strain of Lactobacillus rhamnosus was inoculated into 300 mL of seed culture medium at 2% inoculation rate and incubated at 37°C and 5% CO 2 After 24 h, the inoculum was inoculated into 800 mL of seed culture medium at a rate of 3% and incubated at 37°C with 5% CO. 2 After 10 hours of culturing, the inoculum was inoculated into 200 mL of fermentation medium at a rate of 4%. The fermentation conditions were 35-37°C and anaerobic culture for 8-12 hours. When the cell density in the fermentation liquid reached 10 10 cfu / mL, and the fermentation broth was collected;
[0042] (2) Preparation of freeze-dried bacterial agent: When the temperature of the fermentation liquid of Lactobacillus rhamnosus Glory LG12 drops to about 20°C, centrifuge to collect bacterial sludge, cool the centrifugal bacterial pipeline, collect the bacterial sludge after centrifugation, then add 250g of skim milk powder, 100g of sucrose, and 80g of trehalose as freeze-drying protective agents, dissolve and mix with 1L of distilled water, then spread the mixture evenly on a tray, place the tray on a partition, place a temperature probe in the material, and then freeze-dry, collect the bacterial powder, and store it in a -20°C refrigerator to obtain freeze-dried bacterial powder of Lactobacillus rhamnosus Glory LG12, the number of viable bacteria of which is 10 10 cfu / g.
[0043] Preparation of freeze-dried bacterial powder of Bifidobacterium animalis subspecies lactis XLTG11:
[0044] (1) Liquid submerged fermentation culture: 2% inoculum of the preserved strain of Bifidobacterium animalis subsp. lactis XLTG11 was inoculated into 300 mL of seed culture medium and incubated at 37°C and 5% CO 2After 24 h, the inoculum was inoculated into 800 mL of seed culture medium at a rate of 3% and incubated at 37°C with 5% CO. 2 After 10 hours of culturing, the inoculum was inoculated into 200 mL of fermentation medium at a rate of 4%. The fermentation conditions were 35-37°C and anaerobic culture for 8-12 hours. When the cell density in the fermentation liquid reached 10 10 cfu / mL, and the fermentation broth was collected;
[0045] (2) Preparation of freeze-dried bacterial agent: When the temperature of the fermentation liquid of animal Bifidobacterium lactis subsp. XLTG11 drops to about 20°C, centrifuge to collect bacterial sludge, cool the centrifugal bacterial tube, collect bacterial sludge after centrifugation, then add 250g skim milk powder, 100g sucrose, and 80g trehalose as freeze-drying protective agents, dissolve and mix with 1L distillation, then spread the mixture evenly on a tray, place the tray on a partition, place a temperature probe in the material, and then freeze-dry, collect bacterial powder, and store it in a -20°C refrigerator to obtain freeze-dried bacterial powder of animal Bifidobacterium lactis subsp. XLTG11, the number of viable bacteria of which is 10 10 cfu / g.
[0046] Example 1
[0047] A method for preparing a composite probiotic composition containing Lactobacillus rhamnosus Glory LG12, comprising the following steps:
[0048] The probiotic mixture and the functional mixture are evenly mixed to obtain a probiotic mixture composed of 10g of Lactobacillus paracasei Glory LP16 freeze-dried powder, 7g of Lactobacillus rhamnosus Glory LG12 freeze-dried powder, 6g of Bifidobacterium animalis subspecies lactis XLTG11 freeze-dried powder, and 5g of Lactobacillus acidophilus LA-06 freeze-dried powder; and the functional mixture is composed of 40g of Pueraria lobata extract, 25g of Rosa roxburghii extract and 20g of a composite carrier.
[0049] Wherein, the preparation method of the Pueraria root extract is as follows:
[0050] 20g of kudzu root powder was added to 400g of deionized water, followed by 0.9g of cellulase and 0.6g of amylase, the pH was adjusted to 5.5, and the mixture was enzymolyzed at 38°C for 1.5h. After the enzymolysis was completed, the enzyme was inactivated by microwave, filtered, and the residue was dried for later use; the filtrate was concentrated to 1 / 3 of the volume under reduced pressure at a pressure of 50kpa and a temperature of 80°C, 4 times the volume of anhydrous ethanol was added for alcohol precipitation, followed by centrifugation, the precipitate was collected, and dried to obtain a filtrate extract; 10g of the residue was added to 100g of deionized water, followed by inoculation of 0.18g of yeast, and fermented at 33°C for 22h. After the fermentation was completed, the supernatant was collected by centrifugation and sterilized at 105°C for 20min, and the deionized water was removed by vacuum distillation of the supernatant at a pressure of 40kpa and a temperature of 75°C to obtain a residue extract; 5g of the filtrate extract was evenly mixed with 3g of the residue extract to obtain the product.
[0051] The preparation method of the roxburghii extract is as follows:
[0052] The dried roxburghii fruit was crushed and added into petroleum ether, and refluxed for deesterification for 3 times, each time for 3 hours, filtered, and the roxburghii residue was dried to obtain pretreated roxburghii powder; 10g of the pretreated roxburghii powder was added into 250g of deionized water, followed by 0.8g of citric acid, and extracted at 85°C for 3h. After the extraction, the supernatant was taken and concentrated under reduced pressure to 1 / 3 of the volume. The pressure of the reduced pressure concentration was 40kpa and the temperature was 75°C. 4 times the volume of anhydrous ethanol was added for alcohol precipitation, centrifuged, and the precipitate was washed and freeze-dried to obtain the roxburghii extract.
[0053] The preparation method of the composite carrier is as follows:
[0054] Add 7g zinc oxide and 18g diatomaceous earth into 500mL deionized water, then add 5g citric acid, stir and react at 75℃ for 2.5h, filter, wash and dry after the reaction to obtain a diatomaceous earth / zinc oxide complex; add 7g lecithin and 3g cholesterol into 120g anhydrous ethanol, ultrasonically treat at 250W power for 25min to obtain a mixed solution; add 25g diatomaceous earth / zinc oxide complex into 130g mixed solution, react at a constant temperature of 55℃ for 3.5h, centrifuge, filter, wash and dry after the reaction to obtain a composite carrier.
[0055] Example 2
[0056] A method for preparing a composite probiotic composition containing Lactobacillus rhamnosus Glory LG12, comprising the following steps:
[0057] The probiotic mixture and the functional mixture are evenly mixed to obtain the probiotic mixture, wherein the probiotic mixture is formed by mixing 8g of Lactobacillus paracasei Glory LP16 freeze-dried powder, 5g of Lactobacillus rhamnosus Glory LG12 freeze-dried powder, 4g of Bifidobacterium animalis subspecies lactis XLTG11 freeze-dried powder, and 3g of Lactobacillus acidophilus LA-06 freeze-dried powder; and the functional mixture is formed by 35g of Pueraria root extract, 20g of Rosa roxburghii extract and 15g of a composite carrier.
[0058] Wherein, the preparation method of the Pueraria root extract is as follows:
[0059] 20g of kudzu root powder was added to 300g of deionized water, followed by 0.6g of cellulase and 0.8g of amylase, and the pH was adjusted to 5. The enzyme was hydrolyzed at 35°C for 2h. After the enzymatic hydrolysis was completed, the enzyme was inactivated by microwave, filtered, and the filter residue was dried for later use; the filtrate was concentrated under reduced pressure to 1 / 3 of the volume, the pressure of the reduced pressure concentration was 40kpa, and the temperature was 75°C, 4 times the volume of anhydrous ethanol was added for alcohol precipitation, followed by centrifugation, the precipitate was collected, and dried to obtain a filtrate extract; 10g of the filter residue was added to 80g of deionized water, followed by inoculation of 0.15g of yeast, and fermented at 30°C for 24h. After the fermentation was completed, the supernatant was collected by centrifugation and sterilized at 105°C for 20min, and the deionized water was removed by reduced pressure distillation of the supernatant, the pressure of the reduced pressure distillation was 50kpa, and the temperature was 80°C to obtain a filter residue extract; 5g of the filtrate extract was evenly mixed with 2g of the filter residue extract to obtain.
[0060] The preparation method of the roxburghii extract is as follows:
[0061] The dried roxburghii fruit was crushed and added into petroleum ether, and refluxed for deesterification for 3 times, each time for 3 hours, filtered, and the roxburghii residue was dried to obtain pretreated roxburghii powder; 10g of the pretreated roxburghii powder was added into 200g of deionized water, followed by 0.5g of citric acid, and extracted at 80°C for 4h. After the extraction, the supernatant was taken and concentrated under reduced pressure to 1 / 3 of the volume. The pressure of the reduced pressure concentration was 50kpa and the temperature was 80°C. 4 times the volume of anhydrous ethanol was added for alcohol precipitation, centrifuged, and the precipitate was washed and freeze-dried to obtain the roxburghii extract.
[0062] The preparation method of the composite carrier is as follows:
[0063] Add 5g zinc oxide and 15g diatomaceous earth into 500mL deionized water, then add 3g citric acid, stir and react at 70℃ for 3h, filter, wash and dry after the reaction is completed to obtain a diatomaceous earth / zinc oxide complex; add 5g lecithin and 2g cholesterol into 100g anhydrous ethanol, ultrasonically treat for 30min at 200W power to obtain a mixed solution; add 20g diatomaceous earth / zinc oxide complex into 100g mixed solution, react at a constant temperature of 50℃ for 4h, centrifuge, filter, wash and dry after the reaction is completed to obtain a composite carrier.
[0064] Example 3
[0065] A method for preparing a composite probiotic composition containing Lactobacillus rhamnosus Glory LG12, comprising the following steps:
[0066] The probiotic mixture and the functional mixture are evenly mixed to obtain a probiotic mixture composed of 12g of Lactobacillus paracasei Glory LP16 freeze-dried powder, 10g of Lactobacillus rhamnosus Glory LG12 freeze-dried powder, 7g of animal Bifidobacterium lactis subspecies XLTG11 freeze-dried powder, and 8g of Lactobacillus acidophilus LA-06 freeze-dried powder; and the functional mixture is composed of 45g of Pueraria lobata extract, 30g of Rosa roxburghii extract and 25g of a composite carrier.
[0067] Wherein, the preparation method of the Pueraria root extract is as follows:
[0068] 20g of kudzu root powder was added to 500g of deionized water, followed by 1.2g of cellulase and 0.4 of amylase, and the pH was adjusted to 6. The enzyme was hydrolyzed at 40°C for 1h. After the enzymatic hydrolysis was completed, the enzyme was inactivated by microwave, filtered, and the filter residue was dried for later use; the filtrate was concentrated to 1 / 3 of the volume under reduced pressure at a pressure of 40kpa and a temperature of 75°C, 4 times the volume of anhydrous ethanol was added for alcohol precipitation, followed by centrifugation, the precipitate was collected, and dried to obtain a filtrate extract; 10g of the filter residue was added to 20g of deionized water, followed by inoculation of 0.2g of yeast, and fermented at 35°C for 18h. After the fermentation was completed, the supernatant was collected by centrifugation and sterilized at 105°C for 20min, and the deionized water was removed by vacuum distillation of the supernatant at a pressure of 40kpa and a temperature of 75°C to obtain a filter residue extract; 5g of the filtrate extract was evenly mixed with 4g of the filter residue extract to obtain.
[0069] The preparation method of the roxburghii extract is as follows:
[0070] The dried roxburghii fruit was crushed and added into petroleum ether, and refluxed for deesterification for 3 times, each time for 3 hours, filtered, and the roxburghii residue was dried to obtain pretreated roxburghii powder; 10g of the pretreated roxburghii powder was added into 300g of deionized water, followed by 1g of citric acid, and extracted at 90°C for 2h. After the extraction, the supernatant was taken and concentrated under reduced pressure to 1 / 3 of the volume. The pressure of the reduced pressure concentration was 40kpa and the temperature was 75°C. 4 times the volume of anhydrous ethanol was added for alcohol precipitation, centrifuged, and the precipitate was washed and freeze-dried to obtain the roxburghii extract.
[0071] The preparation method of the composite carrier is as follows:
[0072] Add 8g zinc oxide and 22g diatomaceous earth into 500mL deionized water, then add 6g citric acid, stir and react at 80℃ for 2h, filter, wash and dry after the reaction is completed to obtain a diatomaceous earth / zinc oxide complex; add 10g lecithin and 4g cholesterol into 150g anhydrous ethanol, ultrasonically treat at 300W power for 20min to obtain a mixed solution; add 30g diatomaceous earth / zinc oxide complex into 50g mixed solution, react at a constant temperature of 60℃ for 3h, centrifuge, filter, wash and dry after the reaction is completed to obtain a composite carrier.
[0073] Comparative Example 1
[0074] A method for preparing a composite probiotic composition containing Lactobacillus rhamnosus Glory LG12, comprising the following steps:
[0075] Evenly mix 10 g of Lactobacillus paracasei Glory LP16 freeze-dried powder, 7 g of Lactobacillus rhamnosus Glory LG12 freeze-dried powder, 6 g of Bifidobacterium animalis subspecies lactis XLTG11 freeze-dried powder, and 5 g of Lactobacillus acidophilus LA-06 freeze-dried powder to obtain the product.
[0076] Comparative Example 2
[0077] A method for preparing a composite probiotic composition comprises the following steps:
[0078] The probiotic mixture and the functional mixture are evenly mixed to obtain a probiotic mixture composed of 16g of animal Bifidobacterium lactis subspecies XLTG11 freeze-dried powder and 12g of Lactobacillus acidophilus LA-06 freeze-dried powder, and the functional mixture is composed of 40g of Pueraria root extract, 25g of Rosa roxburghii extract and 20g of zinc oxide.
[0079] Wherein, the preparation method of the Pueraria root extract is as follows:
[0080] 20g of kudzu root powder was added to 400g of deionized water, followed by 0.9g of cellulase and 0.6g of amylase, the pH was adjusted to 5.5, and the mixture was enzymolyzed at 38°C for 1.5h. After the enzymolysis was completed, the enzyme was inactivated by microwave, filtered, and the residue was dried for later use; the filtrate was concentrated to 1 / 3 of the volume under reduced pressure at a pressure of 50kpa and a temperature of 80°C, 4 times the volume of anhydrous ethanol was added for alcohol precipitation, followed by centrifugation, the precipitate was collected, and dried to obtain a filtrate extract; 10g of the residue was added to 100g of deionized water, followed by inoculation of 0.18g of yeast, and fermented at 33°C for 22h. After the fermentation was completed, the supernatant was collected by centrifugation and sterilized at 105°C for 20min, and the deionized water was removed by vacuum distillation of the supernatant at a pressure of 40kpa and a temperature of 75°C to obtain a residue extract; 5g of the filtrate extract was evenly mixed with 3g of the residue extract to obtain the product.
[0081] The preparation method of the roxburghii extract is as follows:
[0082] The dried roxburghii fruit was crushed and added into petroleum ether, and refluxed for deesterification for 3 times, each time for 3 hours, filtered, and the roxburghii residue was dried to obtain pretreated roxburghii powder; 10g of the pretreated roxburghii powder was added into 250g of deionized water, followed by 0.8g of citric acid, and extracted at 85°C for 3h. After the extraction, the supernatant was taken and concentrated under reduced pressure to 1 / 3 of the volume. The pressure of the reduced pressure concentration was 40kpa and the temperature was 75°C. 4 times the volume of anhydrous ethanol was added for alcohol precipitation, centrifuged, and the precipitate was washed and freeze-dried to obtain the roxburghii extract.
[0083] The composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 prepared in Example 1-3 and Comparative Example 1-2 was subjected to a mouse test, as follows:
[0084] 70 SPF male BALB / c mice were randomly divided into 7 groups, 10 in each group. BALB / c mice, 6-8 weeks old, weighing 18-22 g, were provided by Liaoning Changsheng Biotechnology Co., Ltd., animal license number: SCXK (Liao) 2020-0001, and the grouping is shown in Table 1. The experimental animals were kept in a barrier environment animal room with a temperature of 22°C, a humidity of 40-70%, and a 12-h light-dark cycle. They were fed with standard feed, adaptively fed for 1 week, and had free access to water. The blank control group was gavaged with an equal volume of normal saline, and the other groups were first gavaged with ampicillin antibiotics to disrupt the flora, and then the treatment dose of 300 μL ampicillin (1 mg / mL) was continuously gavaged once a day for 14 days. After the model was established, the probiotic composition of each group was made into a 25 mg / mL solution, and then the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 in Example 1 was gavaged in Group 1, the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 in Example 2 was gavaged in Group 2, the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 in Example 2 was gavaged in Group 3, the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 in Example 3 was gavaged in Group 1 of Comparative Example 1, and the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 in Comparative Example 2 was gavaged in Group 2 of Comparative Example 2. The gavage dose of each group was 0.4 mL / 20 g BW, blank control group and model group were gavaged with equal volume of normal saline, and the test samples were given for 14 days. The specific groups are shown in Table 1.
[0085]
[0086] 1. Weight changes
[0087] The initial fasting weight of mice and the fasting weight at the end of the experiment. The results are shown in Table 2
[0088] Table 2 Table 2 Changes in mouse body weight (mean, n = 10)
[0089]
[0090]
[0091] Note: The difference in weight gain is the difference between the weight gain of each group and the weight gain of the model group.
[0092] As can be seen from Table 2 above, the weight of each group increased, but the weight gain of the model group was significantly lower than that of the blank group, indicating that the model group was successfully established, and the weight gain of G3-G5 was significantly higher than that of the model group (p<0.05), indicating that the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 prepared by the present invention can significantly promote the recovery and growth of mouse weight, and the G3-G5 group is better than the G6-G7 group (p<0.05). The difference in weight gain values of the G3-G5 group was not significantly different from that of the blank group, but was significantly higher than that of the G6 and G7 groups, and was higher than the sum of the differences in weight gain values of the G6 and G7 groups (G3 group: p<0.01; G4, G5 groups: p<0.05). Considering that the G6 group is a full probiotic group (4 probiotics) and the G7 group is a probiotic and functional mixture group (Bifidobacterium lactis subspecies XLTG11, Lactobacillus acidophilus LA-06, Pueraria extract, Rosa roxburghii extract and zinc oxide). Comparative analysis of the weight gain values and the difference in weight gain values of G5 and G6 showed that the contribution of Lactobacillus paracasei Glory LP16 and Lactobacillus rhamnosus GloryLG12 to weight gain was greater than that of zinc oxide; analysis of the weight gain values and the difference in weight gain values between the G3-G5 group and the G6-G7 group showed that there was a synergistic promotion effect between the probiotic mixture and the functional mixture in the composite probiotic composition of the present invention, making its effect better than the simple effect superposition. Among them, the synergistic promotion effect of the G3 group was particularly prominent (p<0.01).
[0093] 2. Changes in intestinal flora
[0094] Before giving the test sample, 0.1g of feces in the mouse anus was aseptically taken, 10 times serial dilution, and the appropriate dilution was selected to be inoculated on each culture medium. After cultivation, the colonies were counted by identification of colony morphology, Gram staining microscopy, biochemical reaction, etc., and the number of bacteria in each gram of wet feces was calculated, and statistical processing was performed after taking the logarithm. 24h after the last administration of the test sample, rectal feces were taken in the same way as before the experiment, and the intestinal flora was detected, and the method was the same as above. Changes in bifidobacteria, lactobacilli, enterococci, enterobacteria, and Clostridium perfringens were observed.
[0095] 3. Determination of intestinal permeability
[0096] The levels of LPS and D-lactic acid in the intestine were determined using a kit.
[0097] from Figure 1 It can be seen that compared with the control group (G1), ampicillin changed the composition of the intestinal flora of mice, and had different degrees of influence on different microbial flora. In the feces of the model group (G2), Enterococcus, Enterobacter and Clostridium perfringens increased significantly, while Lactobacillus and Bifidobacterium decreased significantly. Compared with the model group (G2), the fecal flora of mice fed with Example 1-3 groups (G3-G5) increased significantly, and Clostridium perfringens decreased significantly, indicating that the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 prepared by the present invention increased the content of beneficial bacteria and restored some strains to normal flora content, which has a significant repair effect on intestinal flora imbalance and maintains the balance of intestinal microflora. Figure 1 The mean values (LogCFU / g) in A were further analyzed. The mean values of G2 group were 5.77, the mean values of G3 group were 7.37 (the difference between the mean values of G4 and G5 groups and G3 group was less than ±0.3; therefore, G3 group was used as a representative for comparative analysis), the mean values of G6 group were 6.44, and the mean values of G7 group were 6.52. The mean differences between G3, G6, G7 and G2 group were 1.6, 0.67, and 0.75, respectively. The mean difference between G3 group and G2 group was significantly higher than the mean difference between G6, G7 and G2 group (p<0.05), and higher than the sum of the mean differences between G6, G7 and G2 group (p<0.01). This indicates that there is a synergistic effect between the probiotic mixture and the functional mixture in the composite probiotic composition containing Lactobacillus rhamnosus GloryLG12. This result is consistent with the result of weight gain, indicating that the composite probiotic composition of the present invention can promote intestinal health and nutrient absorption by regulating intestinal flora, thereby improving body weight.
[0098] LPS and D-lactic acid are important indicators for detecting intestinal barrier damage at the molecular level. This study used ELISA kits to detect the levels of LPS and D-lactic acid in mouse serum and studied the repair of intestinal barrier permeability in mice by a composite probiotic composition containing Lactobacillus rhamnosus Glory LG12. Figure 2 As shown in the figure, compared with the control group, the content of LPS and D-lactic acid in the model group was significantly increased, indicating that ampicillin can significantly increase the intestinal barrier permeability. Compared with the model group, the content of D-lactic acid in Example 1-3 groups (G3-G5) was significantly reduced, so the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 maintained the LPS intestinal barrier permeability to a greater extent. Figure 2As can be seen in A, the mean of group G2 is 19.43, the mean of group G3 is 15.32, the mean of group G6 is 17.43, and the mean of group G7 is 17.5. Compared with groups G6 and G7, group G3 has significantly reduced LPS content and maintained LPS intestinal barrier permeability to a greater extent, indicating that the probiotic mixture and the functional mixture in the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 have a synergistic effect. This result is consistent with the weight gain result, indicating that the composite probiotic composition of the present invention can improve body weight by regulating intestinal flora, maintaining intestinal barrier function, promoting intestinal health and nutrient absorption.
[0099] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A composite probiotic composition containing Lactobacillus rhamnosus Glory LG12, characterized in that: The composite probiotic composition consists of a probiotic mixture and a functional mixture, wherein the probiotic mixture is a mixture of Lactobacillus paracasei GloryLP16, Lactobacillus rhamnosus Glory LG12, Bifidobacterium animalis subspecies lactis XLTG11, and Lactobacillus acidophilus LA-06, and the functional mixture is a mixture of Pueraria lobata extract, Rosa roxburghii extract, and a composite carrier; Wherein, the Lactobacillus paracasei Glory LP16 is classified and named as Lactobacillus paracasei, and is deposited in the General Microbiology Center (CGMCC) of the China Microbiological Culture Collection Administration, address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, with a deposit date of September 9, 2022 and a deposit number of CGMCC No. 25669; The Lactobacillus rhamnosus Glory LG12 is classified and named as Lactobacillus rhamnosus, and is deposited in the General Microbiology Center (CGMCC) of the China Microbiological Culture Collection Administration, address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, with a deposit date of September 9, 2022 and a deposit number of CGMCC No. 25668; The substance Bifidobacterium lactis subspecies XLTG11 is classified and named as: Bifidobacterium animalis subspecies Bifidobacterium lactis, and is deposited in the General Microbiology Center (CGMCC) of the China Microbiological Culture Collection Administration, address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, with a deposit date of October 25, 2019 and a deposit number of CGMCC No. 18738; The preparation method of the Pueraria root extract is as follows: The kudzu root powder is added to deionized water, followed by the addition of cellulase and amylase, and the pH is adjusted to 5-6 for enzymolysis. After the enzymolysis is completed, the enzyme is inactivated by microwave, filtered, and the filter residue is dried for later use; the filtrate is concentrated under reduced pressure to 1 / 3 of the volume, the pressure of the reduced pressure concentration is 40-50 kpa, and the temperature is 75-80°C, 4 times the volume of anhydrous ethanol is added for alcohol precipitation, followed by centrifugation, the precipitate is collected, and dried to obtain a filtrate extract; the filter residue is added to deionized water, followed by inoculation of yeast, and fermentation is carried out. After the fermentation is completed, the supernatant is collected by centrifugation and sterilized at 105°C for 20 minutes, and the deionized water is removed by reduced pressure distillation of the supernatant, the pressure of the reduced pressure distillation is 40-50 kpa, and the temperature is 75-80°C to obtain a filter residue extract; the filtrate extract and the filter residue extract are evenly mixed to obtain; The preparation method of the roxburghii extract is as follows: The dried roxburgh fruit is crushed and added to petroleum ether, and refluxed for deesterification for 3 times, each time for 3 hours, filtered, and the roxburgh residue is dried to obtain pretreated roxburgh powder; the pretreated roxburgh powder is added to deionized water, and then citric acid is added to perform water extraction. After the water extraction is completed, the supernatant is taken and concentrated under reduced pressure to 1 / 3 of the volume. The pressure of the reduced pressure concentration is 40-50kpa and the temperature is 75-80°C. 4 times the volume of anhydrous ethanol is added for alcohol precipitation, centrifuged, and the precipitate is washed and freeze-dried to obtain the roxburgh extract.
2. The composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 according to claim 1, characterized in that: The mass ratio of the Lactobacillus paracasei Glory LP16, Lactobacillus rhamnosus Glory LG12, Bifidobacterium animalis subspecies lactis XLTG11, and Lactobacillus acidophilus LA-06 is 8-12:5-10:4-7:3-8; the mass ratio of the Pueraria extract, the Rosa roxburghii extract, and the composite carrier is 35-45:20-30:15-25.
3. The composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 according to claim 1, characterized in that: The mass ratio of the probiotic mixture to the functional mixture is 20-35:70-100.
4. The composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 according to claim 1, characterized in that: The material-liquid ratio of the kudzu root powder and deionized water is 1:15-25; the amount of the cellulase added is 3-6% of the mass of the kudzu root powder, and the amount of the amylase added is 2-4% of the mass of the kudzu root powder; the temperature of the enzymolysis is 35-40°C, and the time is 1-2h.
5. The composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 according to claim 1, characterized in that: The solid-liquid ratio of the filter residue and deionized water is 1:8-12, and the amount of the yeast added is 1.5-2% of the mass of the filter residue; the fermentation temperature is 30-35°C and the time is 18-24h; the mass ratio of the filtrate extract to the filter residue extract is 5:2-4.
6. The composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 according to claim 1, characterized in that: The mass ratio of the pretreated roxburghii powder, deionized water and citric acid is 10:200-300:0.5-1, the water extraction temperature is 80-90°C, and the extraction time is 2-4h.
7. The composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 according to claim 1, characterized in that: The preparation method of the composite carrier is as follows: 5-8g zinc oxide and 15-22g diatomaceous earth are added to 500mL deionized water, and then 3-6g citric acid is added, and the mixture is stirred and reacted at 70-80°C for 2-3h. After the reaction is completed, the mixture is filtered, washed, and dried to obtain a diatomaceous earth / zinc oxide complex. 5-10g lecithin and 2-4g cholesterol are added to 100-150g anhydrous ethanol, and the mixture is ultrasonically treated at a power of 200-300W for 20-30min to obtain a mixed solution. 20-30g diatomaceous earth / zinc oxide complex is added to 100-150g of the mixed solution, and the mixture is reacted at a constant temperature of 50-60°C for 3-4h. After the reaction is completed, the mixture is centrifuged, filtered, washed, and dried to obtain a composite carrier.
8. Use of the composite probiotic composition containing Lactobacillus rhamnosus Glory LG12 as claimed in any one of claims 1 to 7 in the preparation of a product for regulating intestinal flora.
Citation Information
Patent Citations
Bifidobacterium lactis MN-Gup improves obesity and its characteristic gut microbiota and its uses
CN113209139B
Medical formula food for hepatic encephalopathy
CN105614851A
Probiotic composition
CN113907361A
